UnitedHealth Group Inc (NYSE:UNH) Shares Purchased by LexAurum Advisors LLC
LexAurum Advisors LLC increased its position in UnitedHealth Group Inc (NYSE:UNH) by 0.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,740 shares of the healthcare conglomerate’s stock after buying an additional 65 shares during the period. UnitedHealth Group comprises 1.1% of LexAurum Advisors LLC’s portfolio, making the stock its 15th largest holding. LexAurum Advisors LLC’s holdings in UnitedHealth Group were worth $2,725,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 7.5% during the 2nd quarter. Vanguard Group Inc. now owns 80,727,140 shares of the healthcare conglomerate’s stock valued at $23,810,470,000 after acquiring an additional 5,654,194 shares during the last quarter. State Street Corp increased its holdings in shares of UnitedHealth Group by 0.5% during the 1st quarter. State Street Corp now owns 46,003,796 shares of the healthcare conglomerate’s stock worth $11,472,427,000 after buying an additional 212,240 shares during the last quarter. Nuveen Asset Management LLC raised its position in shares of UnitedHealth Group by 4.4% in the 2nd quarter. Nuveen Asset Management LLC now owns 7,294,171 shares of the healthcare conglomerate’s stock worth $2,151,416,000 after buying an additional 305,797 shares during the period. Sanders Capital LLC boosted its holdings in UnitedHealth Group by 3.3% in the second quarter. Sanders Capital LLC now owns 5,422,137 shares of the healthcare conglomerate’s stock valued at $1,787,646,000 after acquiring an additional 172,998 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in UnitedHealth Group by 0.8% during the second quarter. Charles Schwab Investment Management Inc. now owns 4,794,237 shares of the healthcare conglomerate’s stock valued at $1,414,060,000 after acquiring an additional 39,532 shares during the period. 86.39% of the stock is currently owned by institutional investors and hedge funds.
UNH traded up $4.87 during trading hours on Friday, hitting $330.60. 2,349,525 shares of the stock were exchanged, compared to its average volume of 2,721,790. The stock has a market cap of $314.18 billion, a price-to-earnings ratio of 18.99, a price-to-earnings-growth ratio of 1.53 and a beta of 0.68. The stock has a 50-day simple moving average of $313.06 and a 200-day simple moving average of $300.72. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.84. UnitedHealth Group Inc has a 12 month low of $187.72 and a 12 month high of $335.65.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $320.59, for a total value of $4,808,850.00. Following the sale, the director now directly owns 159,215 shares of the company’s stock, valued at $51,042,736.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Marianne D. Short sold 10,336 shares of the firm’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $312.34, for a total value of $3,228,346.24. Insiders sold 37,336 shares of company stock worth $11,893,276 in the last three months. 0.80% of the stock is currently owned by corporate insiders.
Several equities analysts have recently weighed in on the company. UBS Group lifted their target price on shares of UnitedHealth Group from $319.00 to $330.00 and gave the company a “neutral” rating in a report on Friday, October 16th. ValuEngine raised UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Thursday, October 1st. Oppenheimer increased their target price on UnitedHealth Group from $353.00 to $375.00 and gave the company an “outperform” rating in a research note on Thursday, October 15th. Royal Bank of Canada boosted their price target on UnitedHealth Group from $384.00 to $389.00 and gave the stock an “outperform” rating in a research report on Thursday, October 15th. Finally, Mizuho reaffirmed a “buy” rating and issued a $315.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, July 15th. Five analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $346.68.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What are trading strategies for the 52-week high/low?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.